[KLK] QoQ Annualized Quarter Result on 30-Jun-2015 [#3]

Announcement Date
19-Aug-2015
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2015
Quarter
30-Jun-2015 [#3]
Profit Trend
QoQ- 4.35%
YoY- -16.73%
View:
Show?
Annualized Quarter Result
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Revenue 16,080,720 17,351,204 13,649,991 12,957,210 12,359,172 12,457,972 11,129,973 27.77%
PBT 2,307,948 3,644,372 1,134,598 1,202,784 1,181,698 1,177,356 1,317,697 45.25%
Tax -272,698 -323,348 -250,560 -257,784 -272,694 -267,932 -285,003 -2.89%
NP 2,035,250 3,321,024 884,038 945,000 909,004 909,424 1,032,694 57.12%
-
NP to SH 1,927,484 3,180,840 869,912 911,498 873,480 856,804 991,705 55.67%
-
Tax Rate 11.82% 8.87% 22.08% 21.43% 23.08% 22.76% 21.63% -
Total Cost 14,045,470 14,030,180 12,765,953 12,012,210 11,450,168 11,548,548 10,097,279 24.58%
-
Net Worth 9,808,334 10,276,918 9,668,055 8,775,317 8,383,277 8,258,993 7,752,950 16.95%
Dividend
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Div 319,489 - 479,143 212,993 319,565 - 585,731 -33.21%
Div Payout % 16.58% - 55.08% 23.37% 36.59% - 59.06% -
Equity
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Net Worth 9,808,334 10,276,918 9,668,055 8,775,317 8,383,277 8,258,993 7,752,950 16.95%
NOSH 1,064,965 1,064,965 1,064,763 1,064,965 1,065,219 1,065,676 1,064,965 0.00%
Ratio Analysis
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
NP Margin 12.66% 19.14% 6.48% 7.29% 7.35% 7.30% 9.28% -
ROE 19.65% 30.95% 9.00% 10.39% 10.42% 10.37% 12.79% -
Per Share
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 1,509.98 1,629.27 1,281.97 1,216.68 1,160.25 1,169.02 1,045.10 27.77%
EPS 181.00 298.80 81.70 85.60 82.00 80.40 93.10 55.70%
DPS 30.00 0.00 45.00 20.00 30.00 0.00 55.00 -33.21%
NAPS 9.21 9.65 9.08 8.24 7.87 7.75 7.28 16.95%
Adjusted Per Share Value based on latest NOSH - 1,064,965
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 1,463.23 1,578.84 1,242.05 1,179.01 1,124.60 1,133.59 1,012.75 27.77%
EPS 175.39 289.43 79.16 82.94 79.48 77.96 90.24 55.67%
DPS 29.07 0.00 43.60 19.38 29.08 0.00 53.30 -33.22%
NAPS 8.9249 9.3513 8.7972 7.9849 7.6282 7.5151 7.0546 16.95%
Price Multiplier on Financial Quarter End Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 -
Price 24.00 22.88 21.70 21.40 22.78 22.80 21.08 -
P/RPS 1.59 1.40 1.69 1.76 1.96 1.95 2.02 -14.73%
P/EPS 13.26 7.66 26.56 25.00 27.78 28.36 22.64 -29.97%
EY 7.54 13.05 3.76 4.00 3.60 3.53 4.42 42.72%
DY 1.25 0.00 2.07 0.93 1.32 0.00 2.61 -38.75%
P/NAPS 2.61 2.37 2.39 2.60 2.89 2.94 2.90 -6.77%
Price Multiplier on Announcement Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 16/05/16 17/02/16 18/11/15 19/08/15 20/05/15 16/02/15 19/11/14 -
Price 23.10 23.66 22.68 20.22 22.40 23.18 23.00 -
P/RPS 1.53 1.45 1.77 1.66 1.93 1.98 2.20 -21.48%
P/EPS 12.76 7.92 27.76 23.62 27.32 28.83 24.70 -35.59%
EY 7.84 12.62 3.60 4.23 3.66 3.47 4.05 55.26%
DY 1.30 0.00 1.98 0.99 1.34 0.00 2.39 -33.34%
P/NAPS 2.51 2.45 2.50 2.45 2.85 2.99 3.16 -14.22%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment